Sami T. Tuomivaara

Sami T. Tuomivaara

Auto-generated profile, based on publicly available information

Sami T. Tuomivaara

Department of Laboratory Medicine, University of California, San Francisco, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
IFIan D. Ferguson
Ian D. Ferguson
BPBonell Patiño-Escobar
Bonell Patiño-Escobar
STSami T. Tuomivaara
Sami T. Tuomivaara
YLYu-Hsiu T. Lin
Yu-Hsiu T. Lin
MNMatthew A. Nix
Matthew A. Nix
AWArun P. Wiita
Arun P. Wiita
The myeloma surface proteome (surfaceome) determines tumor interaction with the microenvironment and serves as an emerging arena for therapeutic development. Here, we use glycoprotein capture proteomics to define the myeloma surfaceome at baseline, in drug resistance, and in response to acute drug treatment. We provide a scoring system for surface antigens and identify CCR10 as a promising target in this disease expressed widely on malignant plasma cells. We engineer proof-of-principle chimeric antigen receptor (CAR) T-cells targeting CCR10 using its natural ligand CCL27. In myeloma models we identify proteins that could serve as markers of resistance to bortezomib and lenalidomide, including CD53, CD10, EVI2B, and CD33. We find that acute lenalidomide treatment increases activity of MUC1-targeting CAR-T cells through antigen upregulation. Finally, we develop a miniaturized surface proteomic protocol for profiling primary plasma cell samples with low inputs. These approaches and datasets may contribute to the biological, therapeutic, and diagnostic understanding of myeloma.

2 March 2022 in Nature
Verified
Journal Article
Closed access
PDF file
GRG. Rizzuto
G. Rizzuto
JBJ. F. Brooks
J. F. Brooks
STS. T. Tuomivaara
S. T. Tuomivaara
TMT. I. McIntyre
T. I. McIntyre
SMS. Ma
S. Ma
AEA. Erlebacher
A. Erlebacher

29 August 2024 in Communications Biology
Verified
Journal Article
Open access
PDF file
STSami T. Tuomivaara
Sami T. Tuomivaara
CTChin Fen Teo
Chin Fen Teo
YJYuh Nung Jan
Yuh Nung Jan
AWArun P. Wiita
Arun P. Wiita
LJLily Y. Jan
Lily Y. Jan
To facilitate our understanding of proteome dynamics during signaling events, robust workflows affording fast time resolution without confounding factors are essential. We present Surface-exposed protein Labeling using PeroxidaSe, H2O2, and Tyramide-derivative (SLAPSHOT) to label extracellularly exposed proteins in a rapid, specific, and sensitive manner. Simple and flexible SLAPSHOT utilizes recombinant soluble APEX2 protein applied to cells, thus circumventing the engineering of tools and cells, biological perturbations, and labeling biases. We applied SLAPSHOT and quantitative proteomics to examine the TMEM16F-dependent plasma membrane remodeling in WT and TMEM16F KO cells. Time-course data ranging from 1 to 30 min of calcium stimulation revealed co-regulation of known protein families, including the integrin and ICAM families, and identified proteins known to reside in intracellular organelles as occupants of the freshly deposited extracellularly exposed membrane. Our data provide the first accounts of the immediate consequences of calcium signaling on the extracellularly exposed proteome.

26 March 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
STSami T. Tuomivaara
Sami T. Tuomivaara
CTChin Fen Teo
Chin Fen Teo
YJYuh Nung Jan
Yuh Nung Jan
LJLily Y. Jan
Lily Y. Jan
AWArun P. Wiita
Arun P. Wiita
To facilitate our understanding of the often rapid and nuanced dynamics of extracellularly exposed proteomes during signaling events, it is important to devise robust workflows affording fast time resolution without biases and confounding factors. Here, we present S urface-exposed protein La beling using P eroxida S e, H 2 O 2 , and T yramide-derivative (SLAPSHOT), to label extracellularly exposed proteins in a rapid, sensitive, and specific manner, while preserving cellular integrity. This experimentally simple and flexible method utilizes recombinant soluble APEX2 peroxidase that is applied to cells, thus circumventing biological perturbations, tedious engineering of tools and cells, and labeling biases. APEX2 neither requires metal cations for activity nor contains disulfide bonds, conferring versatility for a wide spectrum of experimental setups. We applied SLAPSHOT followed by quantitative mass spectrometry-based proteomics analysis to examine the immediate and extensive cell surface expansion and ensuing restorative membrane shedding upon the activation of Scott syndrome-linked TMEM16F, a ubiquitously expressed calcium-dependent phospholipid scramblase and ion channel. Time-course data ranging from one to thirty minutes of calcium stimulation using wild-type and TMEM16F deficient cells revealed intricate co-regulation of known protein families, including those in the integrin and ICAM families. Crucially, we identified proteins that are known to reside in intracellular organelles, including ER, as occupants of the freshly deposited membrane, and mitovesicles as an abundant component and contributor to the extracellularly exposed proteome. Our study not only provides the first accounts of the immediate consequences of calcium signaling on the extracellularly exposed proteome, but also presents a blueprint for the application of SLAPSHOT as a general approach for monitoring extracellularly exposed protein dynamics. Highlights: An enzyme-driven method to tag extracellularly exposed proteins in an unbiased manner with a superior combination of temporal resolution, spatial specificity, and sensitivity A general approach applicable to primary and scarce cells without involving cellular engineering Short time scale proteome dynamics of Jurkat cells with and without TMEM16F revealed by SLAPSHOT coupled with quantitative mass spectrometry provide insights into phospholipid scrambling-mediated plasma membrane remodeling

23 April 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
IFIan D. Ferguson
Ian D. Ferguson
YLYu-Hsiu T. Lin
Yu-Hsiu T. Lin
CLChristine Lam
Christine Lam
Hao ShaoHao Shao
Hao Shao
MHMartina Hale
Martina Hale
AWArun P. Wiita
Arun P. Wiita
Proteasome inhibitor (PI) resistance remains a central challenge in multiple myeloma. To identify pathways mediating resistance, we first map proteasome-associated genetic co-dependencies. We identify cytosolic heat shock protein 70 (HSP70) chaperones as potential targets, consistent with proposed mechanisms of myeloma tumor cells overcoming PI-induced stress. These results lead us to explore allosteric HSP70 inhibitors (JG compounds) as myeloma therapeutics. We show these compounds exhibit increased efficacy against acquired and intrinsic PI-resistant myeloma models, unlike HSP90 inhibition. Surprisingly, shotgun and pulsed-SILAC proteomics reveal that JGs overcome PI resistance not via the expected mechanism of inhibiting cytosolic HSP70s, but instead through mitochondrial-localized HSP70, HSPA9, destabilizing the 55S mitoribosome. Analysis of myeloma patient data further supports strong effects of global proteostasis capacity, and particularly HSPA9 expression, on PI response. Our results characterize dynamics of myeloma proteostasis networks under therapeutic pressure while motivating further investigation of HSPA9 as a specific vulnerability in PI-resistant disease.

1 November 2017 in Analytica Chimica Acta
Verified
Journal Article
Closed access
STSami T. Tuomivaara
Sami T. Tuomivaara
PSPaul Schliekelman
Paul Schliekelman
ANAlison V. Nairn
Alison V. Nairn
KMKelley W. Moremen
Kelley W. Moremen
WYWilliam S. York
William S. York